Work

Phase I trial combining pembrolizumab and doxorubicin in patients with metastatic triple negative breast cancer.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.e13071

Authors: Yuan Yuan, Xuan Ge, Susan Elaine Yost, Jin Sun Lee, Paul Henry Frankel, Christopher Ruel, Yujie Cui, Mireya Murga, Aileen Tang, Norma Martinez, Misagh Karimi, George Somlo, Joanne E. Mortimer, James Ross Waisman

Institutions: City Of Hope National Medical Center, Beverly Hills Cancer Center, City of Hope

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4282011894

Cites:

Cited by: 1

Related to: 10